Copyright by ICR Publishers 2010
|
|
- Leonard Cameron
- 6 years ago
- Views:
Transcription
1 The Association of Heart Valve Diseases with Coronary Artery Dominance Gwilym M. Morris 1, Anthony L. Innasimuthu 2, Jonathan P. Fox 3, Raphael A. Perry 4 1 Division of Cardiovascular and Endocrine Sciences, University of Manchester, 2 University Hospital Aintree, Liverpool, 3 Southport and Ormskirk NHS Trust, 4 The Cardiothoracic Centre, Liverpool, United Kingdom Background and aim of the study: Aortic stenosis (AS) is thought to be caused by calcific degeneration of the aortic valve. Clinical observations suggest an association between a left dominant coronary circulation and AS, a situation previously investigated at necropsy and with small observational studies. Mitral regurgitation (MR) and aortic regurgitation (AR) are both disorders with multiple etiologies, but neither has any known association with coronary artery dominance. Methods: The coronary angiogram database of a tertiary referral centre was reviewed for consecutive left heart catheter data acquired over a six-year period. The severity of AS was classified by measured pressure gradient (in mmhg) as none (0), mild (<30), moderate (30-49), or severe (>49). Both, MR and AR were assessed visually by the operator. Results: A total of 1,891 patients was included. In the AS group there was a significant association with a left dominant coronary circulation (p <0.0001), and the proportion of patients with left dominance increased with the severity of AS (p <0.005). There was no significant association of AR with coronary artery dominance (p = 0.84). MR was associated with a reduced prevalence of left dominance (p <0.005). Conclusion: AS was associated with a left dominant coronary circulation, and the incidence of left dominance was increased with the severity of AS, but the opposite situation was true for MR. The reasons for these observations remain unclear. The Journal of Heart Valve Disease 2010;19: Heart valve disease is a common cause of morbidity and mortality. During a routine left heart catheterization, hemodynamic data regarding aortic stenosis (AS), aortic regurgitation (AR) and mitral regurgitation (MR) can be obtained. Among these conditions, AS is the most common, with a prevalence of 2% by the age of 65 years (1). Known risk factors for AS are similar to those for atherosclerosis, and include hypertension, hypercholesterolemia, and smoking (1). Evidence shows that over 80% of AS is caused by calcific degeneration (2), a process which shares histological and molecular mechanisms with atherosclerosis, including lipid deposition, inflammation, macrophage infiltration, and consequent calcification (3-5). Despite these similarities, there is evidence that AS is a distinct disease, since most patients with atherosclerosis do not develop AS, and aggressive lipid-lowering Address for correspondence: Dr. Gwilym M. Morris, Department of Cardiac Electrophysiology, 3rd Floor, Core Technology Facility, Grafton St., Manchester M13 9NT, UK gwilym.morris@postgrad.man.ac.uk therapy does not affect AS disease progression (6,7). Hence, despite its high prevalence the underlying process of AS is not fully understood. It has been suggested that the development of AS is due to endothelial shear stress (3,8) and, indeed, it is conceivable that the fractional distribution of blood flow to the left and right coronary ostia might cause variations in shear stress on the aortic surface of the aortic valve. The results of necropsy studies have suggested an association between a left dominant coronary artery circulation and congenital bicuspid aortic valve (9,10), while other smaller studies have proposed a correlation between AS and a left dominant circulation (11,12). Aortic regurgitation may coexist with degenerative AS, but has many other causes that include connective tissue disorders (e.g., Marfan s syndrome and pseudoxanthoma elasticum), infective endocarditis, and dilatation of the aortic root. In western countries, the major causes of significant MR are degenerative (e.g., myxomatous disease, flail leaflets, annular calcification), representing 60-70% of cases, ischemic MR (representing 20%), endocarditis (2-5%), and rheumatic (2-5%). Ischemic disease most likely represents a larger Copyright by ICR Publishers 2010
2 390 Valve disease and coronary dominance Table I: Dataset requirements for inclusion in the sample for each valve lesion. Valve lesion AS AR MR proportion of mild MR cases (13). To date, however, no association between these regurgitant valve disorders and coronary artery dominance has been reported. Left heart catheterization allows the assessment of AS (via the withdrawal gradient), MR (by visual assessment at left ventriculography), and AR (by visual assessment at aortography). The dominance of the coronary artery system can easily be determined from coronary angiography by studying the supply of the posterior descending artery. In the present study, a large left heart catheter database was studied to investigate the association between AS, AR and MR and coronary artery dominance. Herein, the data are presented which show that coronary artery dominance is a previously unrecognized risk factor for both AS and MR. Materials and methods Data pressure gradient (mmhg) severity (none, mild, moderate or severe) severity (none, mild, moderate or severe) LVEF: Left ventricular ejection fraction A retrospective review was conducted of the left heart catheter data from a tertiary referral center (the Cardiothoracic Centre, Liverpool, UK) for the period between 1st January 2000 and 31st December Inclusion in the sample set for each valve lesion required a complete record of the parameters for that valve, as described in Table I. The severity of AS was classified by the measured aortic valve pressure gradient as: none (0 mmhg); mild (1-29 mmhg); moderate (30-49 mmhg); or severe (>49 mmhg). The severity of AR and MR was assessed visually by the operator. For each valve lesion, contingency tables were constructed to study the association with a dominant left coronary artery circulation. Statistical analyses were performed using the chisquare test for independence, and for linear trend using software from StatsDirect (Altrincham, UK). Results J Heart Valve Dis Among a total of 2,027 patients who underwent angiography, 1,938 were included in the initial sample. Eighty-nine were excluded from the study due to insufficient data (dominance was not mentioned in 37 patients, and the ejection fraction was <30% in the remaining 52). Aortic stenosis A total of 1,891 patients was identified with a complete AS data set (Table II). The presence of AS was associated with a dominant left coronary circulation (Fig. 1; p <0.0001). A linear trend analysis showed that an increasing severity of AS was associated with an increased prevalence of left dominance (p = ). Aortic regurgitation A total of 1,265 patients was identified with complete Table II: Numbers of coronary angiograms identified with complete data for each sample group. Condition Left dominant Right dominant Co-dominant Total coronary artery coronary artery coronary arteries Aortic stenosis None Mild Moderate Severe Aortic regurgitation None Mild Moderate Severe Mitral regurgitation None Mild Moderate Severe
3 J Heart Valve Dis Valve disease and coronary dominance 391 Figure 1: Aortic stenosis (AS) is associated with a dominant left coronary circulation (p <0.0001). This association shows a linear trend with increasing severity of stenosis (p = ). Figure 2: There was no significant association between the prevalence of aortic regurgitation (AR) and the coronary arterial dominance. AR data (Table II). The presence of AR had no significant association with a left dominant circulation (Fig. 2; p = 0.17). Mitral regurgitation A total of 744 patients was identified with sufficient MR data (Table II). Patients with MR were less likely to have a left dominant coronary circulation (Fig. 3; p = ), an association which showed a linear trend (p = ). Discussion The data acquired showed that a dominance of the coronary artery system has an association with the presence of AS and MR. Furthermore, this association shows a linear trend with increasing severity of the valve lesion. When taken in the context of current knowledge, such an observation provides some insight into the underlying pathology of these diseases. During the early 20th century, the most common cause of heart valve disease was rheumatic fever. However, the incidence of this condition has steadily declined over the past three decades, such that today the most common cause of AS is calcific degeneration (14). Both, mitral valve degeneration and cardiac ischemia are today the most common causes of MR (15,16). Non-rheumatic causes are incompletely understood, especially in the case of AS. Calcific AS, which may occur in both the tricuspid and bicuspid valves, is a degenerative disease that is characterized by thickening and macroscopic nodular calcification of the aortic aspect of the valve cusps, leading to a reduced excursion of the valve leaflets and an obstruction of ventricular outflow. Histological examination shows the presence of fibrosis, lipid accumulation, and macrophage infiltration (4,5), an appearance which bears similarities to arterial atherosclerotic plaques. Moreover, both conditions share many risk factors, including hypercholesterolemia, hypertension, smoking, and diabetes. There is, however, a significant discordance between the development of the two diseases, in that not all patients with AS have coronary artery disease, and vice versa. How then, might this situation, and also the association of left dominance with AS, be accounted for? The simplest explanation is one of altered hemodynamics at the valve level. The increased rate of calcification of unicuspid and bicuspid aortic valves has been attributed in part to such a phenomenon (3). A small nondominant right coronary artery could mean a greater volume of blood flowing into the left mainstem coronary artery; furthermore, the pressure waves of blood flow in the right and left coronary arteries would differ. In the left coronary artery the flow is pulsatile, and this may cause an increase in endothelial shear stress (17). Consequently, a change in flow rate and pressure wave (especially at the left coronary valve cusp) may subject the endothelium of the aortic valve to an increased shear stress, which is known to cause arterial calcification and plaque formation (18). A similar process could be occurring at the level of the aortic valve in the presence of a dominant left coronary artery. Shear stress has been shown to regulate matrix metalloproteinase and cathepsin activity in porcine aortic valves, leading to an increase in the extracellular matrix compared to the cell content, and consequent valve remodeling (19). It is possible that an inherited predisposition for the development of AS may be genetically linked to a left
4 392 Valve disease and coronary dominance J Heart Valve Dis Study limitations The primary limitation was that the results might have been biased, as the data were acquired from patients who were sufficiently symptomatic as to warrant an invasive investigation. However, to perform cardiac catheterization on asymptomatic or minimally symptomatic patients solely to determine a coronary artery dominance would clearly be unethical (27). The present results have provided some indications as to the mechanisms of AS and MR. In clinical practice, when arterial dominance is recognized, it might be used as a factor to help predict the likelihood of disease progression. Figure 3: Mitral regurgitation (MR) is associated with a reduced prevalence of a dominant left coronary artery circulation. There is an inverse correlation between the severity of MR and left dominance. dominant circulation. Indeed, there is evidence of a genetic contribution to AS, with familial clustering of AS having been identified in western France (20). A vitamin D receptor polymorphism has also been associated with AS, as have a number of apolipoprotein E alleles, suggesting a polygenic contribution to the disease (21,22). The genetic determinism of the coronary artery dominance is not known, however. As identical twins may have different arterial dominances (23), it is tempting to conclude that dominance is a result of nurture in utero, and that nature bears little influence. Yet, it is more likely that both play a role, such that a genetic disposition towards left dominance is modulated on a local level during cardiac development. This view is supported by the known association of bicuspid aortic valves and a left dominant circulation (9,24). The anatomy of the bicuspid valve is unable to influence the development of the coronary arteries, as the arteries develop from distal to proximal and join to the aorta at a later stage. Thus, this association must be due to factors other than the valve itself (25). In contrast, the major causes of MR are degenerative (60-70%), ischemic MR (20%), endocarditic (2-5%) and rheumatic (2-5%) (13). The results of the present study showed that a left dominant coronary circulation would protect against MR, and would mean the presence of a large circumflex artery. As the circumflex artery is closely related to the posterior aspect of the mitral valve annulus, where the valve is least well supported by connective tissue, a large circumflex artery might strengthen the annulus in this area. This might explain why circumflex territory infarction caused the most MR in a sheep model of myocardial infarction (26). References 1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29: Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: A European experience. Curr Probl Cardiol 2007;32: Ramaraj R, Sorrell VL. Degenerative aortic stenosis. Br Med J 2008;336: O Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16: Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O Brien KD. Characterization of the early lesion of degenerative valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90: Otto CM, O Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001;85: Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359: Otto CM. Calcific aortic stenosis - time to look more closely at the valve. N Engl J Med 2008;359: Hutchins GM, Nazarian IH, Bulkley BH. Association of left dominant coronary arterial system with congenital bicuspid aortic valve. Am J Cardiol 1978;42: Scholz DG, Lynch JA, Willerscheidt AB, Sharma RK, Edwards JE. Coronary arterial dominance associated with congenital bicuspid aortic valve. Arch Pathol Lab Med 1980;104: Chandrasekar B, Sudarsana G, Abraham KA. Aortic valve disease and left dominant coronary system: A significant association. J Assoc Physicians India
5 J Heart Valve Dis Valve disease and coronary dominance ;48: Murphy ES, Rosch J, Rahimtoola SH. Frequency and significance of coronary arterial dominance in isolated aortic stenosis. Am J Cardiol 1977;39: Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009;373: Davies MJ, Treasure T, Parker DJ. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: Relation to valve morphology. Heart 1996;75: Boudoulas H, Sparks EE, Wooley CF. Mitral valvular regurgitation: Etiology, pathophysiologic mechanisms, clinical manifestations. Herz 2006;31: Luxereau P, Dorent R, De GG, Bruneval P, Chomette G, Delahaye G. Aetiology of surgically treated mitral regurgitation. Eur Heart J 1991;12(Suppl.B): Chatzizisis YS, Giannoglou GD, Parcharidis GE, Louridas GE. Is left coronary system more susceptible to atherosclerosis than right? A pathophysiological insight. Int J Cardiol 2007;116: Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49: Platt MO, Xing Y, Jo H, Yoganathan AP. Cyclic pressure and shear stress regulate matrix metalloproteinases and cathepsin activity in porcine aortic valves. J Heart Valve Dis 2006;15: Probst V, Le SS, Legendre A, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 2006;113: Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85: Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation 2003;108: Frings AM, Mayer B, Bocker W, et al. Comparative coronary anatomy in six twin pairs with coronary artery disease. Heart 2000;83: Higgins CB, Wexler L. Reversal of dominance of the coronary arterial system in isolated aortic stenosis and bicuspid aortic valve. Circulation 1975;52: Waldo KL, Kumiski DH, Kirby ML. Association of the cardiac neural crest with development of the coronary arteries in the chick embryo. Anat Rec 1994;239: Timek TA, Lai DT, Tibayan F, et al. Ischemia in three left ventricular regions: Insights into the pathogenesis of acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2003;125: Lozner EC, Johnson LW, Johnson S, et al. Coronary arteriography : A report of the Registry of the Society for Cardiac Angiography and Interventions. II. An analysis of 218 deaths related to coronary arteriography. Cathet Cardiovasc Diagn 1989;17:11-14
Aortic stenosis (AS) is common with the aging population.
New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting
More informationCoronary arterial anatomy in bicuspid aortic valve
Br Heart Y 1981; 45: 142-7 Coronary arterial anatomy in bicuspid aortic valve Necropsy study of 100 hearts PAUL K LERER,* WILLIAM D EDWARDS From the Department of Pathology and Anatomy and from the Mayo
More informationEtiology of Valvular Heart Disease in the 21 st Century
Etiology of Valvular Heart Disease in the 21 st Century Genetic and Molecular Mechanisms Harisios Boudoulas, MD, Dr, Dr Hon. Professor, Academician (ant. mem.) The Ohio State University, USA Biomedical
More informationBy the end of this session, the student should be able to:
Valvular Heart disease HVD By Dr. Ashraf Abdelfatah Deyab VHD- Objectives By the end of this session, the student should be able to: Define and classify valvular heart disease. Enlist the causes of acquired
More informationType of Valvular Heart Disease Requiring Surgery in the 21 st Century: Mortality and Length-of-Stay Related to Surgery
104 The Open Cardiovascular Medicine Journal, 2013, 7, 104-109 Send Orders of Reprints at reprints@benthamscience.net Open Access Type of Valvular Heart Disease Requiring Surgery in the 21 st Century:
More informationPercutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat
Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,
More informationGender Differences in Valvular Heart Disease. Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences
Gender Differences in Valvular Heart Disease Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences Obstacles Interest in gender differences is a relatively new phenomenon Registries/RCT
More informationFor unclear reasons, only about 40% of patients with calcific aortic stenosis also have coronary
Αθηροσκλήρωση και ασβεστοποιός στένωση της αορτικής βαλβίδας. Οµοιότητες και διαφορές Ν. Μεζίλης Κλινική «Άγιος Λουκάς» Ασβεστοποιός στένωση της αορτικής βαλβίδας: Μία ακόµα µορφή αθηρωµάτωσης; Some observations
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationWorldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates
Michael Sumners DO Epidemiology Worldwide rheumatic fever is the most common cause of valve disease In industrialized areas, valvular disease of old age predominates Calcific aortic stenosis Functional
More informationFirst Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always
ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 2 First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not T D, J P. Citation T D, J P.. First Transfemoral
More informationPrimary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017
Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board
More informationAortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -
Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo
More informationCopyright by ICR Publishers 2006
Lower Serum Calcium Levels are Associated with Greater Calcium Hydroxyapatite Deposition in Native Aortic Valves of Male Patients with Severe Calcific Aortic Stenosis Jan R. Ortlepp 1, Manuela Pillich
More informationAlthough the leading cause of aortic stenosis (AS)
Aortic stenosis (AS) is a narrowing or obstruction of the aortic valve and is the third most prevalent form of cardiovascular disease in the Western world after hypertension and coronary artery disease.
More informationCalcific aortic stenosis is the third most common cause of aortic valve disease in developed
Valve disease CALCIFIC AORTIC STENOSIS: FROM BENCH TO THE BEDSIDE EMERGING CLINICAL AND CELLULAR CONCEPTS See end of article for authors affiliations c AETIOLOGY Correspondence to: Nalini M Rajamannan,
More informationImaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013
Imaging in TAVI Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston Scientific, St Jude, BMS imaging, GE Healthcare,
More informationAdult Cardiac Surgery
Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease
More informationPrimary Mitral Regurgitation
EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,
More informationIschemic Mitral Valve Disease: Repair, Replace or Ignore?
Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship
More informationVALVULAR HEART DISEASE
VALVULAR HEART DISEASE Stenosis: failure of a valve to open completely, obstructing forward flow. - almost always due to a chronic process (e.g., calcification or valve scarring). Insufficiency : failure
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More informationEcho in Asymptomatic Mitral and Aortic Regurgitation
2017 ASE Florida Orlando, FL October 9, 2017 10:40 11:00 PM 20 min Grand Harbor Ballroom South Echo in Asymptomatic Mitral and Aortic Regurgitation Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology
More informationNew Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology
New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.
More informationDisclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech
Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular
More informationAortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants
Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Martin G. Keane, MD, FASE Professor of Medicine Lewis Katz School of Medicine at Temple University Basic root structure Parasternal
More informationChapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine
Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the
More informationValvular Guidelines: The Past, the Present, the Future
Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationUnusual Causes of Aortic Regurgitation. Case 1
Unusual Causes of Aortic Regurgitation Judy Hung, MD Cardiology Division Massachusetts General Hospital Boston, MA No Disclosures Case 1 54 year old female with h/o cerebral aneurysm and vascular malformation
More informationBicuspid Aortic Valve Hemodynamic Consequences
Bicuspid Aortic Valve Hemodynamic Consequences Hector I. Michelena, MD, FACC, FASE Associate Professor of Medicine Director, intra-operative Echocardiography Disclosures None Happy and honored CP1293058-2
More informationOrganic mitral regurgitation
The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality
More informationImproving Quality of Care for Patients with Heart Valve Disease
Improving Quality of Care for Patients with Heart Valve Disease The Heart Team The Heart Valve Clinic Raphael Rosenhek Department of Cardiology Medical University of Vienna Eurovalve 2016 Brussels, March
More informationPERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL
PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationWhich Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?
Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationVALVULO-METABOLIC RISK IN AORTIC STENOSIS
January 2008 (Vol. 1, Issue 1, pages 21-25) VALVULO-METABOLIC RISK IN AORTIC STENOSIS By Philippe Pibarot, DVM, PhD, FACC, FAHA Groupe de Recherche en Valvulopathies (GRV), Hôpital Laval Research Centre
More informationThe Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD
The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New
More informationCalcified Aortic Sinotubular Ridge: A Source of Coronary Ostial Stenosis or Embolism
1510 JACC Vol. 12, No, 6 December 1988:1510--4 Calcified Aortic Sinotubular Ridge: A Source of Coronary Ostial Stenosis or Embolism KEVIN J. TVETER, MD, JESSE E. EDWARDS, MD, FACC St, Paul, Minnesota This
More informationThe Bicuspid Aortic Valve: New Frontiers in Genetics and Interventions
The Bicuspid Aortic Valve: New Frontiers in Genetics and Interventions Westfälische Wilhelms-Universität Münster Helmut Baumgartner Adult Congenital and Valvular Heart Disease Center Dept. of Cardiology
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationDISCLOSURE. Echocardiography in Systemic Diseases: Questions. Relevant Financial Relationship(s) None. Off Label Usage None 5/7/2018
Echocardiography in Systemic Diseases: Questions Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate
More information8/31/2016. Mitraclip in Matthew Johnson, MD
Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure
More informationValvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust
Valvular Heart Disease: Assessment and Timing of Intervention Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust Disclosures: Speaker fee: Bayer Acknowledgements: Matt Shun-Shin
More informationEdwards' solution for patients suffering from tricuspid valve disease
Edwards' solution for patients suffering from tricuspid valve disease R. S. von Bardeleben, MD Head Structural and Heart Valve Center Heart Center Cardiology I, University Medicine Mainz Germany Potential
More informationPercutaneous Valve Interventions. Percutaneous Valve Interventions
Percutaneous Valve Interventions Stanton J. Rowe President, Percutaneous Valve Interventions Edwards is Best Positioned to Capitalize on Percutaneous Valve Opportunities #1 global valve replacement and
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationThe Causes of Heart Failure
The Causes of Heart Failure Andy Birchall HFSN Right heart failure LVSD - HFREF Valve regurgitation or stenosis Dropsy CCF congestive cardiac failure Cor pulmonale Pulmonary hypertension HFPEF LVF Definitions
More informationPercutaneous Mitral Valve Repair
Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral
More informationSevere aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner
Severe aortic stenosis should be operated before symptom onset CONTRA Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center Dept. of Cardiology
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationSpotlight on Valvular Heart Disease Guidelines
Spotlight on Valvular Heart Disease Guidelines Aortic Valve Disease Raphael Rosenhek Department of Cardiology Medical University of Vienna Palermo, April 26 th 2018 1998 2002 2006 2007 2008 2012 2014 2017
More informationECHOCARDIOGRAPHY DATA REPORT FORM
Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationLEFT MAIN DISEASE PATIENT PROFILE
LEFT MAIN DISEASE PATIENT PROFILE MUHAMMAD YOUSUF SHAIKH*, MANSOOR AHMAD*, A RASHEED*, DAD M. JAN*, MANSOOR ALI* Background: Left main coronary artery (LMCA) disease is a potentially lethal disease that
More informationDr.ssa Loredana Iannetta. Centro Cardiologico Monzino
Dr.ssa Loredana Iannetta Centro Cardiologico Monzino Bicuspid aortic valve BAV is the most common congenital cardiac anomaly. Estimated incidence is 2% in general population. 4:1 male predominance. Frequency
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationVALVULOPATIE: NUOVE SOLUZIONI.
VALVULOPATIE: NUOVE SOLUZIONI www.fisiokinesiterapia.biz Nkomo, Lancet 2006 ELDERLY POPULATION PROJECTION IN USA 65-84 Years Old 85 and Older 77,2 Millions of people 34,8 4,3 30,5 53,8 6,8 47 14,3 62,9
More informationManagement of Heart Failure in Adult with Congenital Heart Disease
Management of Heart Failure in Adult with Congenital Heart Disease Ahmed Krimly Interventional and ACHD consultant King Faisal Cardiac Center National Guard Jeddah Background 0.4% of adults have some form
More information가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY
가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY PA c IVS (not only pulmonary valve disease) Edwards JE. Pathologic Alteration of the right heart. In: Konstam MA, Isner M, eds.
More informationLV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital
LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload
More informationValvular Intervention
Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone
More informationValve Analysis and Pathoanatomy: THE MITRAL VALVE
: THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationEmbolic Protection Devices for Transcatheter Aortic Valve Replacement
Embolic Protection Devices for Transcatheter Aortic Valve Replacement James M. McCabe, MD Medical Director, Cardiac Cath Lab University of Washington Seattle, WA Disclosures Proctoring and honoraria for
More informationand Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.
Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular
More informationThe Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal
The Tricuspid Valve: The Not So Forgotten Valve Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal No Conflicts of Interest to declare with regards to this subject 2 INCIDENCE OF TRICUSPID REGURGITATION
More informationMITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center
MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT Irene Frantzis P year, SGUL Sheba Medical Center MITRAL VALVE DISEASE Mitral Valve Regurgitation Mitral Valve Stenosis Mitral Valve Prolapse MITRAL REGURGITATION
More informationNew Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego
New Imaging for Aortic Valve Disease Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego Imaging in Aortic Stenosis Valve morphology calcification
More informationHOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?
HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado
More informationStable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology
Stable Ischemic Heart Disease Ivan Anderson, MD RIHVH Cardiology Outline Review of the vascular biology of atherosclerosis Why not just cath everyone with angina? Medical management of ischemic cardiomyopathy
More informationAneurysms & a Brief Discussion on Embolism
Aneurysms & a Brief Discussion on Embolism Aneurysms, overview = congenital or acquired dilations of blood vessels or the heart True aneurysms -involve all three layers of the artery (intima, media, and
More informationJournal of Radiology Research and Practice
Journal of Radiology Research and Practice Vol. 2015 (2015), Article ID 312482, 25 minipages. DOI:10.5171/2015.312482 www.ibimapublishing.com Copyright 2015. Jonszta Tomas, Pleva Leos, Krivankova Katerina
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationThe Value of Percutaneous Coronary Intervention in Aortic Valve Stenosis with Coronary Artery Disease
The American Journal of Medicine (2007) 120, 185.e7-185.e13 BRIEF OBSERVATION The Value of Percutaneous Coronary Intervention in Aortic Valve Stenosis with Coronary Artery Disease Ronny Alcalai, MD, a
More informationSemiology of the Heart in the 21 st century
Semiology of the Heart in the 21 st century Workshop Rodrigo Salgado Dept of Radiology Antwerp University Hospital - Belgium Question The cardiothoracic index a. Is something I always mention, because
More informationChronic Primary Mitral Regurgitation
Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......
More informationSeverity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root
The role of Cardiac Imaging modalities in evaluation & selection of patients for Trans-catheter Aortic Valve Implantation Dr.Saeed AL Ahmari Consultant Cardiologist Prince Sultan Cardaic Center, Riyadh
More informationDECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D CARDIOLOGO
DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D PER IL CARDIOLOGO GUIDELINES IN ASYMPTOMATIC MR ACC/AHA ESC Antonio Miceli Heart Hospital Monasterio Foundation NATURAL/
More informationOutline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines
Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationAortic Regurgitation & Aorta Evaluation
VALVULAR HEART DISEASE Regurgitation Valvular Lessions 2017 Aortic Regurgitation & Aorta Evaluation Jorge Eduardo Cossío-Aranda MD, FACC Chairman of Outpatient Care Department Instituto Nacional de Cardiología
More informationIn contrast to aortic stenosis, which essentially has 3
Valvular Heart Disease Causes of Pure Aortic Regurgitation in Patients Having Isolated Aortic Valve Replacement at a Single US Tertiary Hospital (1993 to 2005) William Clifford Roberts, MD; Jong Mi Ko,
More informationCase Report Anomalous Left Main Coronary Artery: Case Series of Different Courses and Literature Review
Case Reports in Vascular Medicine Volume 2013, Article ID 380952, 5 pages http://dx.doi.org/10.1155/2013/380952 Case Report Anomalous Left Main Coronary Artery: Case Series of Different Courses and Literature
More informationWhat Are the Current Guidelines for Treating Thoracic Aortic Disease?
What Are the Current Guidelines for Treating Thoracic Aortic Disease? Eric M. Isselbacher, M.D. Director, MGH Healthcare Transformation Lab Co-Director, MGH Thoracic Aortic Center Associate Professor of
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationAortic root reconstructive surgery - new created technique for aortic stenosis
Aortic root reconstructive surgery - new created technique for aortic stenosis Reconstructive surgery of the aortic root Academician d-r Zan Mitrev, T.Anguseva, E.Stoicovski, E Idoski Special hospital
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve
More informationValvular Heart Disease. Dr. HANAN ALBACKR
Valvular Heart Disease Dr. HANAN ALBACKR Valvular Heart Disease Format for this lecture IMPORTANT CLINICAL INFO know for boards, tests and clinical practice Spectrum of VHD Aortic Valve Mitral Valve Tricuspid
More informationCase Report. Percutaneous Mitral Repair with MitraClip as an Adjunct Therapy of Heart Failure. Introduction. Case Report. Keywords
Percutaneous Mitral Repair with MitraClip as an Adjunct Therapy of Heart Failure Petherson Susano Grativvol, 1,2 Katiuska Massucatti Grativvol, 1,2 Alberto de Paula Nogueira Jr., 1,2 João Eduardo Tinoco
More informationAustralia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes
Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes A/ Professor Darren Walters On behalf of the ANZ Source Investigators Director of Cardiology Brisbane, Australia ANZ
More informationCoronary Atherosclerosis in Valvular Heart Disease
Coronary Atherosclerosis in Valvular Heart Disease Jerome Lacy, M.D., Robert Goodin, M.D., Daniel McMartin, M.D., Ronald Masden, M.D., and Nancy Flowers, M.D. ABSTRACT To evaluate the usefulness of routine
More informationMI Acute occlusion of the proximal left anterior descending (LAD) artery is the cause of 40% to 50% of all MIs. *
MI *33% -50% die before hospital lethal arrhythmia Sudden Cardiac Death. * Arrhythmias are caused by electrical abnormalities of the ischemic myocardium and conduction system. *Acute occlusion of the proximal
More informationWelcome 17 Michigan TAVR Participating Hospitals!
Welcome 17 Michigan TAVR Participating Hospitals! 1 MICHIGAN TAVR BRIEF OVERVIEW HOW AND WHY PRE-TAVR IMAGING EVALUATION AND THE TVT Michael Grossman, MD Co-Director, BMC2 Coordinating Center Why Michigan
More information